Old Web
English
Sign In
Acemap
>
authorDetail
>
Nobuaki Sarai
Nobuaki Sarai
AstraZeneca
Medicine
Internal medicine
Hyperkalemia
Sodium zirconium cyclosilicate
Nephrology
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
2020
Clinical and Experimental Nephrology
Naoki Kashihara
Yoshimitsu Yamasaki
Takeshi Osonoi
Hiromasa Harada
Yugo Shibagaki
June Zhao
Hyosung Kim
Toshitaka Yajima
Nobuaki Sarai
Show All
Source
Cite
Save
Citations (2)
Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study
2020
Clinical and Experimental Nephrology
Naoki Kashihara
Toshiki Nishio
Takeshi Osonoi
Yosuke Saka
Toshiyuki Imasawa
Takayasu Ohtake
Hiroshi Mizuno
Yugo Shibagaki
Hyosung Kim
Toshitaka Yajima
Nobuaki Sarai
Show All
Source
Cite
Save
Citations (3)
1